A new clinical practice guideline from the Infectious Diseases Society of America (IDSA) provides detailed instruction on
diagnosis and treatment of diabetic foot infections.
The guideline
notes that not all foot wounds in diabetic patients are infected.
Infections should be diagnosed by the presence of at least
two classic symptoms or signs of inflammation or purulent
secretions, the IDSA said. Infections can then be classified into
mild, moderate or severe. These classifications, along with
vascular assessment, will help determine the need for hospitalization,
surgery or amputation. Imaging is helpful in most cases, the
guideline said, beginning with plain radiographs and progressing
to magnetic resonance imaging if more information is needed.
Hospital admission is recommended for all patients with a
severe infection, selected patients with a moderate infection with
complicating features, patients unable to comply with
outpatient treatment regimens, or patients who fail to improve on
outpatient
therapy. Before discharge, patients should be clinically
stable; have any urgently needed surgery; achieve glycemic control;
be able to manage outpatient self-care; and have a well-defined
plan, an off-loading scheme, specific wound care instructions
and planned follow-up.
For either in- or outpatient treatment, the guideline also
provides instructions on culturing diabetic foot infections and
prescribing antibiotics based on the results of cultures.
Wounds with no evidence of infection do not require antibiotic therapy,
and aerobic gram-positive cocci are the most common causative
organisms of infections, the IDSA said.
Recommendations on how to diagnose and treat osteomyelitis are
also included in the guideline. Multidisciplinary team care
is recommended whenever possible, and the guideline includes
advice on when to refer care to specialists. The appropriate
use of surgical interventions (which are required for most
diabetic foot infections) and best methods of wound care are also
described in the guideline, which is presented as a series of
questions and answers.
The guideline was published online May 22 by Clinical Infectious Diseases.
No comments:
Post a Comment